, Volume 77, Issue 1, pp 93-95

Thrombocytopenia Induced by Imatinib Mesylate (Glivec) in Patients with Chronic Myelogenous Leukemia: is 400 mg Daily of Imatinib Mesylate an Optimal Starting Dose for Japanese Patients?

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access